Burning around $4m a quarter, should get us to mid next year for a capital raise at a higher price. But only 2 trials disclosed, hopefully we have a new trial initiated ever quarter til H2 2025.
1. Phase 2 blood cancer trial
2. CMML German trial
3. iRBD Parkinson’s (more to come)
No mention of Scar treatment though, let’s hope we get an update on this in the next 2 months.
On track, but not bolting out the gates, so probably why we’re still so cheap.
Burning around $4m a quarter, should get us to mid next year for...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $82.87M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.3¢ | 5.0¢ | $89.06K | 1.729M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 765196 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 504954 | 3 |
View Market Depth
| Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
| SNT (ASX) Chart |